Cargando…
Motexafin gadolinium injection for the treatment of brain metastases in patients with non-small cell lung cancer
Despite recent advances in technology, targeting, and chemotherapy, brain metastasis from non-small cell lung cancer (NSCLC) remains a significant problem. The vast majority of patients with this diagnosis undergo whole brain radiation therapy (WBRT). However, outcomes are still quite poor with medi...
Autores principales: | Thomas, Sayana R, Khuntia, Deepak |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2673824/ https://www.ncbi.nlm.nih.gov/pubmed/17722515 |
Ejemplares similares
-
MRI-Monitored Intra-Shunt Local Agent Delivery of Motexafin Gadolinium: Towards Improving Long-Term Patency of TIPS
por: Wang, Han, et al.
Publicado: (2013) -
Systemic treatment of non-small cell lung cancer brain metastases
por: Cedrych, Ida, et al.
Publicado: (2016) -
Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma
por: Rybarczyk-Kasiuchnicz, Agnieszka, et al.
Publicado: (2021) -
The Management of Brain Metastases in Non-Small Cell Lung Cancer
por: Owen, Scott, et al.
Publicado: (2014) -
Surgical Treatment of Non-Small Cell Lung Cancer with Isolated Synchronous Brain Metastases
por: I, Hoseok, et al.
Publicado: (2006)